-
oa The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications
- Source: Current Radiopharmaceuticals, Volume 11, Issue 3, Dec 2018, p. 154 - 155
-
- 01 Dec 2018
There is no abstract available.
© Bentham Science Publishers